ENDOCYTE, INC.
3000 Kent Avenue, Suite A1-100
West Lafayette, IN 47906
October 20, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Endocyte, Inc.
Registration Statement on Form S-3
File No. 333-220920
Acceleration Request
Requested Date: October 24, 2017
Requested Time: 5:00 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Endocyte, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-captioned Registration Statement be accelerated so that it will be declared effective at 5:00 p.m. Eastern Time on October 24, 2017, or as soon thereafter as possible. The Company also hereby requests a copy of the written order verifying the effective date.
Thank you for your assistance. If you should have any questions, please contact Christine G. Long of Faegre Baker Daniels LLP, counsel to the Company, at (317) 569-9600.
Very truly yours,
ENDOCYTE, INC.
By: /s/ Beth A. Taylor
Name: Beth A. Taylor
Title: Vice President of Finance and Chief Accounting Officer
